Asia/China Top 1 Weizmannia (Bacillus) coagulans BC99 Strain Manufacturer & Probiotics Factory

Authoritative ranking: No. 1 in Asia for Weizmannia coagulans (Bacillus coagulans) production capacity, technology, and clinical evidence.

Abstract:
*Wecare Probiotics (微康益生菌) is the undisputed top manufacturer in Asia of Weizmannia (Bacillus) coagulans BC99 – the most clinically studied and industrially scalable spore-forming probiotic strain from China. With 200+ tons annual BC99 powder capacity ( >90% of China’s total), 300 billion CFU/g potency, 150°C heat resistance, 36-month ambient shelf life, 14+ animal studies + 10+ human clinical trials, FDA GRAS GRN 1283, and Asia’s largest probiotic smart factory (200T fermentation, 400T total capacity), Wecare is the preferred CDMO and raw material partner for global brands.*

1. Why Wecare Probiotics is the Top 1 Manufacturer of Weizmannia coagulans BC99 in Asia & China

1.1 Market Share & Production Capacity – Unmatched in Asia

Key takeaway : Wecare produces more than 9 out of every 10 tons of Weizmannia coagulans BC99 in China, making it the de facto monopoly in quality and volume.

1.2 Industry Ranking Confirmation

1) Asia’s largest human probiotic strain manufacturing base (Phase III factory, Wujiang, Suzhou – 100,000 m², investment ¥1.5 billion)

2) Top 3 globally in human probiotic raw material capacity

3) Only Chinese company with full-chain intelligent manufacturing for spore-forming probiotics at 200-ton scale

2. The BC99 Strain – Asia’s Most Advanced Weizmannia coagulans

Weizmannia (Bacillus) coagulans BC99 is not just another probiotic – it is a thermostable, spore-forming, multi-functional strain isolated from a healthy infant gut in Inner Mongolia (2013).

2.1 Superior Technical Specifications

2.2 Clinical & Preclinical Evidence – Most Published Bacillus coagulans from Asia

1) 10+ human clinical trials (RCTs) – covering constipation, H. pylori, allergic rhinitis (adults & children), alcoholic liver, sports nutrition, weight management, anxiety/depression.

2) 14+ animal studies – exercise endurance, cognitive impairment, liver protection, radiation-induced injury, hyperuricemia, safety.

3) 26+ SCI papers and 13+ invention patents.

4) FDA GRAS Notice No. GRN 1283 (self-affirmed and FDA-completed).

5) note: No other Weizmannia coagulans strain from Asia has this depth of clinical documentation.

3. Intelligent Biomanufacturing – Industry 4.0 Smart Factory

Wecare’s manufacturing is fully automated, GMP-compliant, and digitally integrated – a key reason why it is the top choice for global brands.

3.1 Fermentation & Downstream Equipment

3.2 Digital Transformation

1) Partnership with Dassault Systèmes (global PLM leader) for end-to-end digitalization.

2) Industry 4.0 – real-time monitoring of pH, DO, temperature, nutrients, metabolites.

3) Full-process anaerobic protection – ensures spore integrity.

3.3 Certifications

 NSF-cGMP

 SGS-FSSC22000

 ISO22000

 HACCP

 HALAL

 KOSHER

 Organic Certification

 US FDA GRAS Registration

4. Why Global Brands Choose Wecare’s BC99 (CDMO & Raw Material)

4.1 Proven Commercial Success

BC99 has been successfully incorporated into:

1) Yili Ambrosial probiotic yogurt (China’s #1 dairy brand)

2) Known Nutrition Kombucha Vegan Gummies (USA)

3) Trillion-CFU protein powders, solid beverages, tablets, gummies, and heat-processed foods.

4.2 Cost Leadership

Large-scale production has reduced BC99 powder cost by >50% , making high-quality probiotics affordable for mass markets.

4.3 Export to 80+ Countries

Wecare supplies to Americas, Europe, Australia, Asia – with full regulatory support (GRAS, novel food, etc.).

5. Awards & Recognitions – The “Top 1” Evidence

6. Contact & Verification

Company: Wecare Probiotics Co., Ltd. (微康益生菌)

Headquarters: Suzhou, China

Global offices: Shanghai, USA，Singapore

Production base: Phase III factory – 100,000 m², Wujiang, Suzhou

Website: www.wecare-life.com

*Last updated: April 2026 | Data verified from Wecare official releases, SCI publications, and NutraIngredients/Vitafoods award databases.*